Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CTSU N0949 Randomized Phase III Trial of mFOLFOX7 or XELOX Plus Bevacizumab versus 5-Fluorouracil/Leucovorin or Capecitabine Plus Bevacizumab as First


Collapse Overview 
Collapse sponsor award id
CTSUNo949


Collapse Biography 

Collapse Time 
Collapse start date
2011-05-24